baber/WOPTO huggingface dataset:
Patent IE-45608-B1 (IE)
Title: Crucible for the thermal analysis of alloys
IPC: G01N33/20
Filed: 1977-07-05
Abstract: A new crucible for use in the thermal analysis of metal alloys and especially aluminum alloys into which a thermocouple may be placed into a metallic thin-walled sheath which is secured in and extends upwardly from the crucible base and is connected to recording apparatus. The crucible is formed of an extremely thin-walled metallic cylindrical envelope having a base and a cake of heat-insulating material resting inside the envelope on the base, the thermocouple sheath extending upwardly through said cake.
Patent IE-61534-B1 (IE)
Title: Ostomy coupling
Inventor: STEER PETER LESLIE
IPC: A61F5/448
Filed: 1988-05-20
Abstract: An ostomy appliance has four annular parts (10, 20, 30, 40). The first part (10) is attachable to the body of the wearer. It is also attachable to the third part (30) by a second part (20) which comprises a rotatable locking ring. The third part (30) is attachable to the fourth part (40) in a push fit manner and the ostomy bag (46) is connected to the fourth part (40).
Patent IE-45364-B1 (IE)
Title: Novel malonic acid esters and their use in the manufactureof isoindole derivatives
IPC: C07C67/00
Filed: 1977-07-28
Abstract: A process for the preparation of isoindole derivatives which comprises heating a compound of the formula  II wherein R,R1,R2,R3,R4 and R5 are hereinafter set forth, in the presence of a suitable imidazole, is described.
Patent IE-61889-B1 (IE)
Title: "improved resistance heater for diamond production by CVD"
Inventor: ANTHONY THOMAS RICHARD
IPC: C30B25/02
Filed: 1989-05-23
Abstract: A plural substrate CVD apparatus for diamond crystal production utilizes spaced apart vertical, parallel, planar substrate panels with an electrical (direct current, D.C.) resistance filament heater therebetween. A hydrogen-hydrocarbon gas mixture flows between panels to come into contact with the heater and the panels to cause diamond crystal nucleation and growth on the substrate panels. The apparatus includes means for maintaining the spaced relationship of the heater from the substrate surfaces, comprising a rod member attached to one end of the heater and tensioned by a cable passing over a pulley member and attached to a weight.
Patent IE-39843-B1 (IE)
Title: New 2 4-diaryl pyrazolyloxyacetic acid derivatives and process for their manufacture
IPC: A61K31/415
Filed: 1974-09-12
Abstract: Compounds of the formula WHEREIN X and Y each are a bond or methylene, R is H or lower-alkyl and Z is a carboxyl, amide, nitrile or alkoxycarbonyl of 1-6 carbon atoms in the alkoxy group and the corresponding compounds bearing 1-2 halogen, lower-alkyl or lower-alkoxy groups on one or both benzene rings and, when Z is carboxyl, salts thereof with physiologically acceptable bases, possess anti-inflammatory and antipyretic activities.
[US3962453A]
Patent IE-77161-B1 (IE)
Title: Coated veterinary implants
Inventor: CASTILLO ERNESTO JESUS
IPC: A61K9/22
Filed: 1991-06-19
Abstract: Solid dosage forms of bioactive materials for parenteral administration such as porcine or bovine somatotropin pellets intended for subcutaneous implantation to improve food production of farm animals are coated with polyvinyl alcohol to extend the release characteristics of the material. The polyvinyl alcohol preferably has a molecular weight of from about 20,000 to 100,000, a degree of hydrolysis of at least about 98%, and is applied from an aqueous solution by spray coating to form a continuous uniform covering of from about 3 to 25 ug/mm<2> PVA/surface area of pellet.
Patent IE-68680-B1 (IE)
Title: Pyridazinone derivatives
Inventor: REDPATH JAMES
IPC: A61P11/08
Filed: 1989-07-03
Abstract: The invention relates to pyridazinone compounds of the general formula I: wherein R<1> represents one to four substituents, which may be the same or different and are selected from H, OH, halogen, NO2, unsubstituted or C1-C4 alkyl substituted amino, C1-C4 alkyl, C1-C4 halogen substituted alkyl, O-ALK-NR<4>R<5>, C1-C4 alkoxy, whereby two substituents taken together may also represent a methylenedioxy group ; R<2> and R<3> represent independently H or C1-C4 alkyl; R<4> and R<5> represent independently H or C1-C4 alkyl, or form together with the nitrogen a 5- or 6- membered ring; X represents S or O; the dotted line represents an optional bond; and their pharmaceutically acceptable salts. The compounds according to the invention have a cardiotonic, blood platelet aggregation inhibiting, systemic vasodilator, pulmonary vasodilator, and bronchodilator activity, and more particularly they show a very potent increase of the force of the muscular contractions of the heart, reduce afterload on the heart, improve pulmonary blood flow, and improve airways ventilation.
Patent IE-42196-B1 (IE)
Title: S-triazine prepolymers
IPC: C07D251/34
Filed: 1975-12-02
Abstract: 1475219 s-Triazine prepolymers BAYERAG 24 Oct 1975 [3 Dec 1974 5 March 1975] 43756/75 Heading C3R In a process for the preparation of s-triazine prepolymers (a) an aliphatic, cycloaliphatic or aromatic dihydroxy or polyhydroxy compound is condensed with more than 1/3 mol of cyanuric chloride per hydroxyl group and (b) the resulting condensation product is condensed with an aromatic dihydroxy or polyhydroxy compound in such a way that more than 1 hydroxyl group equivalent of the aromatic dihydroxy or polyhydroxy compound is used per unconverted chlorine atom of the condensation product obtained from (a), and (c) thereafter, the free hydroxyl groups of the condensation product obtained from (b) are reacted with a cyanogen halide in the presence of a base. The prepolymers have free cyanate groups which enable them to be cross-linked. In examples the hydroxy compounds reacted with cyanuric chloride in step (a) are ethylene glycol, 1,6- hexanediol, 1,2 - propanediol, 2,2- bis - (4- hydroxycyclohexyl) - propane, 4,41 - dihydroxyphenyl, 2,2 - bis - (3,5 - dimethyl - 4- hydroxyphenyl) - propane, 2,2 - bis - (3,5- dichloro - 4 - hydroxyphenyl) - propane, diethylene glycol, tetraethylene glycol and a polyester having hydroxyl groups and obtained from butane diol, ethylene glycol and adipic acid; the products are condensed in step (b) with 2,2-bis-(p-hydroxyphenyl)-propane, 1,1- bis - (4 - hydroxyphenyl) - cyclohexane, resorcinol and hydroquinone; the products are then reacted in step (c) with cyanogen chloride in the presence of triethylamine to obtain the prepolymers.
Patent IE-59097-B1 (IE)
Title: Method of and device for storing and transforming heat and generating cold
IPC: C09K5/00
Filed: 1987-11-19
Abstract: A method of storing and transforming heat and of generating cold by means of two metal-hydride and metal-hydrogen systems operating in conjunction in closed circulation at different temperatures. Magnesium hydride, especially active magnesium hydride, is employed as a high-temperature hydride. A hydride with a hydrogen-dissociation pressure that is lower than that of the magnesium hydride subject to the conditions of thermal dissociation and higher than that of the magnesium hydride during its recovery is employed as a low-temperature hydride.
Patent IE-60919-B1 (IE)
Title: Preparation of isothiazolones
IPC: C07D275/02
Filed: 1988-11-16
Abstract: Preparation of 3-isothiazolones may be carried out in a single reaction vessel synthesis from 3,3 min -dithiodipropionic acid, 3-thiopropionic acid, or their related acid halide by reacting sequentially with a thionyl halide (if the (di)acid halide has not previously been formed), followed by reaction with halogenating agent, then reaction with primary amine in the presence of acid scavenger, and subsequently with halogenating agent.
Patent IE-61455-B1 (IE)
Title: New 2-(piperazinyl)-2-oxoethylene substituted flanovoid derivatives, processes for preparing them and pharmaceutical compositions containing them
Inventor: ROLLAND YVES
IPC: C07D311/32
Filed: 1988-11-30
Abstract: Compound of general formula I:   <IMAGE> (I)  in which: A is a single or double bond, R1 and R3, which may be identical or different, are each a hydrogen atom, an alkoxycarbonylmethylene radical of formula -CH2CO2R4 (in which R4 denotes an alkyl radical having 1 to 5 carbon atoms) or a radical of formula W:  <IMAGE>  (in which n is equal to 0 or 1 and R5, R6 and R7, which may be identical or different, are each a hydrogen or halogen atom, a hydroxyl radical, a trifluoromethyl radical, a lower alkyl radical containing 1 to 5 carbon atoms or an alkoxy radical containing 1 to 5 carbon atoms), R2 is a hydrogen atom, an alkoxycarbonylmethylene radical of formula -CH2CO2R4, a radical of formula W, or a  beta -glucose or rutinose molecule linked to the oxygen to which it is attached with a glycoside bond, on condition, however, that at least either R1 or R2 or R3 always denotes a radical of formula W, and their addition salts with a pharmaceutically acceptable inorganic or organic acid.
Patent IE-65197-B1 (IE)
Title: Fibrinogen receptor antagonists
Inventor: NUTT RUTH F
IPC: A61P7/02
Filed: 1990-10-12
Abstract: A fibrinogen receptor antagonist of the formula <CHEM> wherein XX represents a synthetic alpha-amino acid containing a linear side chain and ZZ represents a sequence of 1, 2, 3 or 4 amino acids.
Patent IE-81168-B1 (IE)
Title: Novel 5(and/or6)substituted 2-(2-imidazolin-2-YL) nicotinic acids esters and salts useful as herbicidal agents and novel intermediates for the preparation of said nicotinic acids esters and salts
Inventor: DOEHNER ROBERT FRANCIS JR
IPC: C07D413/00
Filed: 1988-12-30
Abstract: There are provided novel 5(and/or 6)substituted 2-(2-imidazolin-2-yl) and 2-(2-imidazolidinyl)nicotinic acids, esters and salts, which are useful as herbicidal agents. There are also provided novel substituted pyrrolopyridine acetonitriles, pyrrolopyridine acetamides, imidazopyrrolopyridinediones and carbamoylnicotinic acid esters, that are useful as intermediates for the preparation of the above said herbicidal agents.
Patent IE-64609-B1 (IE)
Title: Pradimicin derivatives
Inventor: KAMACHI HAJIME
IPC: A61K31/704
Filed: 1990-11-13
Abstract: The present invention provides pradimicin analogs of formula (II) which exhibit improved water solubility relative to parent compounds. These novel agents are useful in treatment of fungal infections. <CHEM> wherein R<1> is selected from the group consisting of H, methyl, and hydroxymethyl, and when R<1> is methyl or hydroxymethyl, the resulting amino acid has the D-configuration;  R<2> is H or  beta -D-xylosyl;  R<3> is H or methyl; and R<4> is selected from the group consisting of (C2-5)alkenyl; (C2-5)alkynyl; substituted (C1-5)alkyl; substituted (C2-5)alkenyl; wherein the substituent for both the alkyl and alkenyl is a group selected from the group consisting of, carboxy, (C1-5)alkoxycarbonyl, carbamyl, (C1-5)alkylcarbamyl, di(C1-5)alkylcarbamyl, and sulfonyl; (C1-5)alkanoyl substituted with a group selected from the group consisting of amino, (C1-5)alkylamino, and di(C1-5)alkylamino; L-glutamyl; formyl; benzyl; and p-tolylsulfonylcarbamyl; or a pharmaceutically acceptable salt thereof.
Patent JP-S5332266-B1 (JP)
IPC: G02C7/04
Filed: 1971-01-19
Abstract: A fused bifocal contact lens having "no jump" characteristics at all points of the segment line separating the distant vision segment of zone from the near vision zone. The lens include conventional convex and concave surfaces on the exterior portions, but, by reason of the construction of the bifocal segment, the wearer does not experience double vision when his line of sight crosses the segment line and the wearer does not notice the presence of the bifocal segment when not looking therethrough. In one form, a full, concentric bifocal segment is provided, and in another form, a lens is provided in which the bifocal segment is of a bi-curve form, lies principally in the lower portion of the lens and is defined by an upper, outer curve and an inner curve forming a partially circular segment line across which there is no jump. Methods of forming such lenses, including the method of forming the near vision segment, forming a composite blank including both distant and near vision segments, and forming a bifocal lens from the composite blank, are described.
Patent JP-2870536-B1 (JP)
Title: 系統連系装置およびその制御装置
IPC: H02J9/06
Filed: 1998-01-20
Granted: 1999-03-17
Abstract: 【要約】
【課題】  商用電源線２５によって受電している受電母 線２２と、自家発電装置２７から給電が行われる自家発 母線２３とのように、２つの電力系統間に介在される系 統連系装置２１において、配電線２６および商用電源線 ２５等の事故に対して、自家発電装置２７が過負荷とな ることによる停電を防止するとともに、重要負荷が接続 される配電線２８の瞬時電圧低下を抑止する。
【解決手段】  系統連系装置２１を、サイリスタＴＨ１ 〜ＴＨ４から成る単相整流回路と、限流作用を行う直流 リアクトルＬとを備えて構成し、制御装置３０は、ＴＨ １，ＴＨ２をスイッチ動作させ、ＴＨ３，ＴＨ４をダイ オード運転し、系統事故時に、ＴＨ１，ＴＨ２をＯＦＦ 駆動しても、素子故障によってＯＦＦしないときには、 再度ＴＨ１，ＴＨ２をＯＮ駆動して直流リアクトルＬの 磁界エネルギを消費する電流還流ループを形成した後、 ＴＨ３，ＴＨ４をＯＦＦ駆動する。
Patent LU-101900-B1 (LU)
Title: Electrical acupoint stimulation method and apparatus for pain adjuvant therapy
Inventor: JIANQIAO FANG
IPC: A61N1/00
Filed: 2020-07-06
Granted: 2021-02-04
Abstract: The present invention discloses an electrical acupoint stimulation method and apparatus for pain adjuvant therapy. The method realises analgesia for pain by means of outputting a bidirectional symmetrical rectangular pulse current with a frequency of 2/120 Hz, when the frequency is 2 Hz, a wave width is 400µs, when the frequency is 120 Hz, a wave width is 100µs, and a sparse wave and a dense wave separately last for 3 seconds. The apparatus for realising the method comprises a pulse generator and an electrode. The present invention may obviously improve secretion of central endogenous enkephalins and ?-endorphinins, inhibit production of peripheral IL-1?, and play a role in anti-inflammation and analgesia, is beneficial to relieving the pain, provides intelligent operation for a patient to independently use an instrument to relieve the pain, and may improve living quality of the pain-suffered patient.
Patent LU-504824-B1 (LU)
Title: Ein spezieller aufzug für rollstühle
Inventor: LU SHAOKAN
IPC: A61G3/00
Filed: 2023-03-15
Granted: 2023-12-01
Abstract: Das Gebrauchsmuster offenbart einen speziellen Aufzug für Rollstühle, der Hubtischgehäuse umfasst, wobei die Hubtischgehäuse mit einem Hubtisch versehen ist, die Hubtischgehäuse eine Hubbasis hat, die an beiden Enden fest verbunden ist, die Hubbasis mit einer Hebevorrichtung installiert ist, das obere Ende der Hebevorrichtung in Kontakt mit der unteren Fläche des Hubtisches ist, der Hubtisch mit einer Schaltvorrichtung zur Steuerung der Hebevorrichtung versehen ist. Das Gebrauchsmuster durch die Einstellung der Hubtisch wird der Rollstuhl leicht Übertragung durch die Stufe Bürgersteig, anwendbar auf die Stufe Bürgersteig innerhalb des Einkaufszentrums, lösen das Problem der behinderten Menschen in Rollstühlen zu passieren Unannehmlichkeiten, machen die behinderten Menschen Passage mehr sicher und bequem. Das Gebrauchsmuster hat eine einfache Struktur und ist einfach zu benutzen.
Patent MD-563-B1 (MD)
Title: Nutritive addition for nurse cows
Inventor: BAHCIVANJI Mihail
IPC: A23K1/16
Filed: 1995-01-27
Abstract: Inventia se refera la agricultura, in special la producerea nutreturilor. Adaosul furajer propus contine vitamine, aminoacizi, microelemente, biostimulator si antioxidant, microelementele cupru, zinc, cobalt si mangan, folosindu-se in forma de complexuri chelatice                    Rezultatul tehnic al inventiei consta in faptul ca adaosul furajer propus stimuleaza activitatea biologica a sistemului fermentativ la rumegatoare si ridica nivelul de asimilare, ceea ce con                                                Revendicari: 1
Patent NO-314458-B1 (NO)
Inventor: KUCHERLAPATI RAJU S
IPC: C07K14/74
Filed: 1991-03-22
Abstract: Homologous recombination is employed to inactivate genes, particularly genes associated with MHC antigenes. Particularly, the beta 2-microglobulin gene is inactivated for reducing or eliminating Class I MHC antigenes. The resulting cells may be used as universal donors. In addition, embryonic stem cells may be modified by homologous recombination for use in producing chimeric or transgenic mammalian hosts.
Patent NO-310297-B1 (NO)
Inventor: DEHENNAU CLAUDE
IPC: C08L3/02
Filed: 1993-02-05
Abstract: Alloy composition exhibiting improved mechanical strength properties. The composition contains a starch, preferably plasticised, and a polymer acting as coupling agent, which is chosen from the group consisting of polyolefins modified with chemical functional groups which are active towards the hydroxyl functional groups of the starch. The composition generally also contains a thermoplastic polymer. The invention also relates to the process for the preparation of this composition and the use of these compositions for the manufacture of films intended for the paper goods market or for biodegradable plastic packaging.
Patent NO-301940-B1 (NO)
Title: Elektrolysecelle av Söderberg-typen
Inventor: PAULSEN KNUT ARNE
IPC: C25C3/22
Filed: 1994-01-07
Abstract: En elektrolysecelle av Søderberg-typen for fremstilling av aluminium, omfatter en katode (1) som rommer et elektrolysebad, en over katoden stasjonært anordnet anodemantelkonstruksjon omsluttende en karbonanode (1) som strekker seg delvis ned i elektrolysebadet, innretninger for tilførsel og uttak av elektrisk likestrøm fra cellen, samt midler for tilsetting av tilsatsmaterialer, f.eks. aluminiumoksid til elektrolysebadet i cellen. Anoden (1) er todelt (6, 7), hvorved anodemantel-konstruksjonen utgjøres av to parallelle med og nær inntil hverandre anordnete manteldeler (8, 9), idet det mellom manteldelene er anordnet et avtagbart deksel eller overbygning (11).
Patent NO-316276-B1 (NO)
Inventor: HOEHN ARTHUR
IPC: C10L1/22
Filed: 1996-08-14
Abstract: PCT No. PCT/EP95/00429 Sec. 371 Date Aug. 12, 1996 Sec. 102(e) Date Aug. 12, 1996 PCT Filed Feb. 7, 1995 PCT Pub. No. WO95/21904 PCT Pub. Date Aug. 17, 1995Carboxylic esters of the formula IR1-CO-O-R2 I,where R1 is an aliphatic, straight-chain or branched hydrocarbon radical having alkyl side chains and a number average molecular weight of from 250 to 5000 and R2 is a straight-chain or branched hydrocarbon radical of 1 to 30 carbon atoms or a radical of the formula II    <IMAGE>  II  where R3, R4, R5 and R6, independently of one another, are each hyrogen, branched or straight-chain alkyl, an aromatic radical or an araliphatic radical which may also contain heteroatoms, R7 and R8, independently of one another, are each branched or straight-chain alkyl or an aromatic or araliphatic radical which may also contain heteroatoms, X is O, S, NR9 or PR9, where R9 is an aliphatic or aromatic radical, n and m, independently of one another, are each from 2 to 20, and x is from 0 to 30, are used as fuel additives or lubricant additives, and fuel compositions or lubricant compositions contain these additives. Carboxylic acids or carboxylic esters are prepared by reacting polymers having at least 30 carbon atoms and at least one carbon-carbon double bond with carbon monoxide and water or an alcohol.
Patent NO-318587-B1 (NO)
Inventor: YOUNG LAWRENCE STERLING
IPC: A61K38/00
Filed: 1997-06-13
Abstract: For the treatment of carcinomas in epithelial cells and for the prevention of epithelial cell proliferation, use is made of a CD40 receptor binder. The CD40 may be used in conjunction with at least one antineoplastic agent and/or CD40 inducer.
Patent NO-321925-B1 (NO)
Inventor: DELUCA HECTOR F
IPC: A61K31/59
Filed: 1999-09-16
Abstract: This invention provides a novel class of vitamin D related compounds, namely, the 2-alkyl-19-nor-vitamin D derivatives, as well as a general method for their chemical synthesis. The compounds have the formula: where Y1 and Y2, which may be the same or different, are each selected from the group consisting of hydrogen and a hydroxy-protecting group, R6 is selected from the group consisting of alkyl, hydroxyalkyl and fluoroalkyl, and where the group R represents any of the typical side chains known for vitamin D type compounds. These 2-substituted compounds are characterized by low intestinal calcium transport activity and high bone calcium mobilization activity resulting in novel therapeutic agents for the treatment of diseases where bone formation is desired, particularly low bone turnover osteoporosis. These compounds also exhibit pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as anti-cancer agents and for the treatment of diseases such as psoriasis.
Patent NO-309420-B1 (NO)
Title: Löfteklype
Inventor: BIRKELAND TORALV K
IPC: B66C3/12
Filed: 1999-10-05
Abstract: Oppfinnelsen vedrører en løfteklype (1) for en langstrakt gjenstand (2), så som en tømmerstokk, hvor løfteklypen kan anbringes ved en skuffe (3) på traktor eller lignende ar-beidsredskap. Videre omfatter løfteklypen (1) middel (4) for montering av denne direkte på skuffen (2); idet monteringsmidlet (4) omfatter to festeplater (5, 6) som, når løftekly-pen (1) er montert, ligger an mot et bunnparti (7) av skuffen (3). Dermed besørges det en mer stabil og kontrollert løfting og transport av gjenstanden (2).
Patent AT-519985-B1 (AT)
Title: Hängeklemme
Inventor: RIO RÖHL
IPC: B60M1/23
Filed: 2017-09-21
Granted: 2018-12-15
Abstract: Eine Hängeklemme zur Verbindung von Tragseilen (1) und Fahrleitungen (2) für elektrisch betriebene Schienenfahrzeuge mittels eines Hängerseiles (3), mit zwei Klemmbacken (6, 7), wobei eine beide Klemmbacken (6, 7) durchsetzende Schraube (8) zur Klemmung der beiden Klemmbacken (6, 7) angeordnet ist. Die Schraube (8) weist quer zu ihrer Längserstreckung eine durchgehende Bohrung (9) auf, durch die das Hängerseil (3) durchgesteckt ist. Eine auf die Schraube (8) aufgeschraubte Mutter (14) klemmt das Hängerseil (3) in der Bohrung (9) fest. Damit kann die Länge des Hängerseils einfach geändert werden.
Patent AT-516538-B1 (AT)
Title: Pistengerät sowie Verfahren zum Betreiben desselben
Inventor: ALEXANDER TROJER
IPC: E01H4/02
Filed: 2015-11-16
Granted: 2016-11-15
Abstract: Die Erfindung betrifft ein Pistengerät (1) zur Präparierung von Skipisten, aufweisend ein Pistenfahrzeug (2) und eine Seilwinde (3) mit einem Seil (4) zur Unterstützung einer Fahrt des Pistenfahrzeuges (2) über einen Untergrund (6). Um ein besonders schnelles Präparieren steiler Hänge bei geringem Kraftstoffverbrauch zu ermöglichen, ist erfindungsgemäß vorgesehen, dass die Seilwinde (3) gesondert vom Pistenfahrzeug (2) an einer Montageposition (5) fix mit dem Untergrund (6) verbindbar ist. Weiter betrifft die Erfindung ein Verfahren zum Betreiben eines Pistengerätes (1) mit einem Pistenfahrzeug (2) und einer Seilwinde (3).
Patent BG-61753-B1 (BG)
Title: Controled release of oxycodone compositions
Inventor: OSHLACK BENJAMIN
IPC: A61K47/44
Filed: 1993-07-20
Abstract: The method for considerable reduction of the amount of thedaily dose required for controlling the pain in approximately 90%of the patients includes the application of oral dose ofcontrolled released oxycodone from 10 to 40 mg oxycodone or itssalt. The form secures maximum plasma content of the oxycodonefrom 6 to 60 ng/ml of the medicament from 2 to 4 1/2 hrs afterapplication and minimum plasma concentration from 3 to 30 ng/mlfrom 10 to 14 hrs after repeated application every 12 hours atconstant conditions. Another alternative implementation forcontrolling the pain in all patients is the application of oralsolid form including up to 160 mg oxycodone or its salt, so thatits maxymum plasma concentration would reach up to 240 ng/ml fromthe medicament from 2 to 4 1/2 hrs after aplication the minimumplasma concentration approaching 120 ng/ml from 10 to 14 hrs afterrepeated application every 12 hours under constant conditions. Theinvention also includes oxycodone forms for attaning the aboveconcentrations.